You have 8 free searches left this month | for more free features.

Major adverse cardiac events

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adverse Events in Pediatric Cardiac Surgery

Completed
  • Congenital Heart Disease in Children
  • +2 more
  • Fluid balance
  • Brussels, Belgium
    Hôpital Universitaire des Enfants Reine Fabiola
Jul 19, 2022

Primary Prevention of Atherosclerotic Cardiovascular Disease Trial (Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran)

Not yet recruiting
  • Primary Prevention of Atherosclerotic Cardiovascular Disease
  • Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL
  • Placebo in 1.5ml
  • (no location specified)
Feb 13, 2023

Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)

Not yet recruiting
  • Coronary Artery Disease Progression
  • Intensive lipid-lowering control
  • Moderate-intensity lipid-lowering control
  • (no location specified)
Jul 13, 2022

Obstructive Hypertrophic Cardiomyopathy

Completed
  • Microvascular Dysfunction
  • +2 more
    • Beijing, Beijing, China
      Fuwai Hospital, China National Center for Cardiovascular Disease
    Jan 11, 2023

    STEMI Trial (PPCI in heavy thrombus burden STEMI patients)

    Not yet recruiting
    • STEMI
    • PPCI in heavy thrombus burden STEMI patients
    • (no location specified)
    Mar 30, 2023

    Vascular Events In Patients Undergoing Same-day Noncardiac

    Recruiting
    • Preoperative Care
    • +2 more
      • Montreal, Quebec, Canada
      • +1 more
      Jul 28, 2022

      Cardiovascular Diseases Trial in Peking (cardiovascular magnetic resonance (CMR))

      Completed
      • Cardiovascular Diseases
      • cardiovascular magnetic resonance (CMR)
      • Peking, Beijing, China
        Chinese PLA General Hospital
      Apr 3, 2022

      In-stent Restenosis, Major Adverse Cardiovascular Events Trial in Beijing (PCSK9 inhibitor, Statin)

      Recruiting
      • In-stent Restenosis
      • Major Adverse Cardiovascular Events
      • Beijing, Beijing, China
        Beijing Anzhen Hospital
      Jan 16, 2023

      Major Adverse Cardiovascular Events for Naldemedine and Other

      Recruiting
      • Opioid-induced Constipation
      • Wilmington, Delaware
        Research Site
      Feb 28, 2022

      GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

      Recruiting
      • Diabetes Mellitus, Type 2
      • Myocardial Infarction
      • PCI
      • Naples, Italy
        Celestino Sardu
      Aug 31, 2023

      Peripheral Arterial Disease Trial in Fribourg, Zurich (sirolimus-coated balloon catheter, uncoated balloon catheter)

      Recruiting
      • Peripheral Arterial Disease
      • sirolimus-coated balloon catheter
      • uncoated balloon catheter
      • Fribourg, Switzerland
      • +1 more
      Mar 4, 2022

      MACE and PE in Elective Primary TKA & THA

      Completed
      • Cardiovascular Complication
      • +4 more
        • Larissa, Greece
          University of Thessaly
        Oct 29, 2021

        Cancer, Drug Toxicity, Atrial Fibrillation Trial in Caen (occurence of atrial fibrillation)

        Recruiting
        • Cancer
        • +3 more
        • occurence of atrial fibrillation
        • Caen, Normandy, France
          Alexandre
        Jul 6, 2022

        Prostate Cancer Trial in United States (Relugolix, Leuprolide Acetate)

        Recruiting
        • Prostate Cancer
        • Tucson, Arizona
        • +7 more
        Feb 1, 2023

        Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

        Not yet recruiting
        • Aortic Valve Stenosis
        • Angiotensin Receptor-Neprilysin Inhibitor
        • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
        • Seoul, Korea, Republic of
          Asan Medical Center
        Jan 4, 2023

        Low-density Lipoprotein Cholesterol Reduction With

        Recruiting
        • Acute Coronary Syndrome
        • Dyslipidemias
        • Banja Luka, Republic Of Srpska, Bosnia and Herzegovina
          University Clinical Centre of the Republic of Srpska
        Oct 17, 2021

        Characterization of Arrhythmia-induced Cardiomyopathy

        Recruiting
        • Cardiomyopathy
        • Arrhythmia-induced Cardiomyopathy (AiCM)
        • Data collection: Major adverse cardiovascular event (MACE) assessment questionnaire (prospective part)
        • +3 more
        • Basel, Switzerland
          University Hospital Basel, Department of Cardiology
        Jan 2, 2023

        Risk Factors for Predictors of MACEs After RA-CABG

        Completed
        • Coronary Artery Disease
          • Shanghai, Shanghai, China
            Ruijin Hospital Shanghai Jiao Tong University School of Medicine
          Nov 30, 2021

          Effect of CVP and IOH on AKI and AKD

          Completed
          • Acute Kidney Injury
          • Acute Kidney Disease
          • Venous congestion
          • Introperation hypotension
          • Nanjing, Jiangsu, China
            Nanjing First Hospital
          Jan 23, 2022

          Atrial Fibrillation and Flutter, Atrial Fibrillation, Postoperative Complications Trial in Leuven (Photoplethysmography based

          Recruiting
          • Atrial Fibrillation and Flutter
          • +3 more
          • Photoplethysmography based smartphone application for heart rhythm analysis (FibriCheck™)
          • Leuven, Belgium
            University Hospitals Leuven
          Aug 16, 2022

          Coronary Artery Disease Trial in Isparta (N-acetyl cysteine, Saline)

          Active, not recruiting
          • Coronary Artery Disease
          • Isparta, Mediterranean Region, Turkey
            Suleyman Demirel University
          Jan 8, 2022

          MACCE According to Time Interval of Taking Medication in Acute

          Completed
          • Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
          • Esomezol Cap
          • Seoul, Korea, Republic of
            Hanmi Pharmaceutical Company Limited
          Aug 2, 2022

          Acute Coronary Syndrome, Brief Supportive Psychotherapy, Intensive Cardiac Care Unit Trial in Jakarta Pusat (Intervention group)

          Completed
          • Acute Coronary Syndrome
          • +2 more
          • Intervention group
          • Jakarta Pusat, DKI Jakarta, Indonesia
            Medical Faculty
          Feb 18, 2020

          PARA-HEART Pilot Implementation

          Completed
          • Acute Coronary Syndrome
          • Chest Pain
            • Winston-Salem, North Carolina
              Wake Forest School Of Medicine
            Mar 3, 2022

            Adverse Events After Cardiac Surgery

            Recruiting
            • Heart; Dysfunction Postoperative, Cardiac Surgery
            • +4 more
              • Boston, Massachusetts
              • +2 more
              May 7, 2021